Teva Pharmaceuticals at heart of major price fixing suit in US - www.israelhayom.com
Teva Pharmaceuticals found to be responsible for its role in the opioid epidemic in New York State | CNN
Teva Pharmaceutical CEO Schultz stepping down in November 2023 - WSJ (TEVA) | Seeking Alpha
Teva Pharmaceuticals Office Photos | Glassdoor
Anything but Generic: A map for Selling to Teva Pharmaceuticals
Teva's (NYSE: TEVA) move of North American HQ to N.J. takes another step forward - Philadelphia Business Journal
Spurred by tax credits, Teva considers move to Parsippany - NJBIZ
$40 million incentive lures global pharmaceutical giant to Parsippany
Teva Pharmaceutical | P3 Properties | NJ Office Market
Teva's picked an address in Parsippany, New Jersey, and the dirt's about to fly | Fierce Pharma
Teva Pharmaceuticals - Wikipedia
Israel's Teva to move US HQ from Pennsylvania to New Jersey | The Times of Israel
Teva selects North Jersey site for its new North American headquarters. - Philadelphia Business Journal
Teva Pharmaceutical gains 6.5% following Florida opioid settlement (NYSE: TEVA) | Seeking Alpha
Teva Pharmaceuticals Launches Generic EpiPen for Children in US | The Jewish Press - JewishPress.com | Hana Levi Julian | 21 Av 5779 – August 21, 2019 | JewishPress.com
Teva will move North American HQ to New Jersey - Kansas City Business Journal
Teva said to 'walk away' from settlement talks in US price-fixing lawsuit | The Times of Israel
Teva Pharmaceutical's US Arm Charged With Price-Fixing
U.S. charges Teva in generic drugs price-fixing probe
Brand-name drug group accepts Teva, a maker of generics - The Boston Globe
Teva to pay Arkansas $931K to settle price-fixing allegations (NYSE:TEVA) | Seeking Alpha
Jerusalem, Israel. 21st Oct, 2019. The Teva Pharmaceutical logo is seen in English and Hebrew at their tablet production plant in Jerusalem, on Monday, October 21, 2019. The Israeli drug manufacturer Teva's
Teva Pharmaceutical Industries Ltd. is moving its North American headquarters from North Wales, Mo… | Teva pharmaceuticals, Pharmaceutical industry, Pharmaceutical
U.S. approval of Teva drug could help reverse company's migraines - The Jerusalem Post
Teva, one of the biggest generic makers, joins the the brand-name club
Teva Posts 2021 Earnings and Puts Opioid Litigation in Rearview Mirror | BioSpace
